 | • レポートコード：MRC2-11QY11532 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はクローン病のグローバル市場について調査・分析したレポートです。種類別（手術、薬物療法）市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別クローン病の競争状況、市場シェア ・世界のクローン病市場：種類別市場規模 2015年-2020年（手術、薬物療法） ・世界のクローン病市場：種類別市場規模予測 2021年-2026年（手術、薬物療法） ・世界のクローン病市場：用途別市場規模 2015年-2020年（病院、外来手術センター、その他） ・世界のクローン病市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、その他） ・北米のクローン病市場分析：米国、カナダ ・ヨーロッパのクローン病市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのクローン病市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のクローン病市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのクローン病市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbvie、Amgen、Cambridge Antibody Technology、Janssen Biotech、Pfizer、Tillotts Pharma、Johnson & Johnson、Boehringer Ingelheim ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Crohn’s disease develop slowly and gradually. Some of the common symptoms of this disease include abdominal pain and cramping, fever, fatigue, diarrhea, blood in stools, appetite and weight loss. Inflammation of skin, joints, and eyes, inflammation of the liver or bile duct, and delayed sexual development in children are some other symptoms associated with severe Crohn’s disease.
Rising number of drug therapies for Crohn’s disease and increasing demand for better diagnostics and treatment options for the auto-immune disease are some of the key factors driving the growth of the global Crohn’s disease market. In addition, rise in the number of patients suffering from auto-immune disorders in developing countries and increasing government initiatives for improving health care infrastructure are fueling the growth of the global Crohn’s disease market. However, less awareness among people about the disease is also restraining the growth of the market. Patent expiry of various useful drugs, such as remicade and humira, is also impeding the growth of the market.
Market Analysis and Insights: Global Crohn’s Disease Market
The global Crohn’s Disease market size is projected to reach US$ 8923 million by 2026, from US$ 8635.6 million in 2020, at a CAGR of 3.1%% during 2021-2026.
Global Crohn’s Disease Scope and Market Size
Crohn’s Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Crohn’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbvie
Amgen
Cambridge Antibody Technology
Janssen Biotech
Pfizer
Tillotts Pharma
Johnson & Johnson
Boehringer Ingelheim
Market segment by Type, the product can be split into
Surgery
Drug Therapy
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Crohn’s Disease Revenue
1.4 Market by Type
1.4.1 Global Crohn’s Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Drug Therapy
1.5 Market by Application
1.5.1 Global Crohn’s Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Market Perspective (2015-2026)
2.2 Global Crohn’s Disease Growth Trends by Regions
2.2.1 Crohn’s Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Crohn’s Disease Historic Market Share by Regions (2015-2020)
2.2.3 Crohn’s Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Crohn’s Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Crohn’s Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Players by Market Size
3.1.1 Global Top Crohn’s Disease Players by Revenue (2015-2020)
3.1.2 Global Crohn’s Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Crohn’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Crohn’s Disease Market Concentration Ratio
3.2.1 Global Crohn’s Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Revenue in 2019
3.3 Crohn’s Disease Key Players Head office and Area Served
3.4 Key Players Crohn’s Disease Product Solution and Service
3.5 Date of Enter into Crohn’s Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Crohn’s Disease Historic Market Size by Type (2015-2020)
4.2 Global Crohn’s Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Crohn’s Disease Market Size by Application (2015-2020)
5.2 Global Crohn’s Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Crohn’s Disease Market Size (2015-2020)
6.2 Crohn’s Disease Key Players in North America (2019-2020)
6.3 North America Crohn’s Disease Market Size by Type (2015-2020)
6.4 North America Crohn’s Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Crohn’s Disease Market Size (2015-2020)
7.2 Crohn’s Disease Key Players in Europe (2019-2020)
7.3 Europe Crohn’s Disease Market Size by Type (2015-2020)
7.4 Europe Crohn’s Disease Market Size by Application (2015-2020)
8 China
8.1 China Crohn’s Disease Market Size (2015-2020)
8.2 Crohn’s Disease Key Players in China (2019-2020)
8.3 China Crohn’s Disease Market Size by Type (2015-2020)
8.4 China Crohn’s Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Crohn’s Disease Market Size (2015-2020)
9.2 Crohn’s Disease Key Players in Japan (2019-2020)
9.3 Japan Crohn’s Disease Market Size by Type (2015-2020)
9.4 Japan Crohn’s Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Crohn’s Disease Market Size (2015-2020)
10.2 Crohn’s Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Crohn’s Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Crohn’s Disease Market Size by Application (2015-2020)
11 India
11.1 India Crohn’s Disease Market Size (2015-2020)
11.2 Crohn’s Disease Key Players in India (2019-2020)
11.3 India Crohn’s Disease Market Size by Type (2015-2020)
11.4 India Crohn’s Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Crohn’s Disease Market Size (2015-2020)
12.2 Crohn’s Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Crohn’s Disease Market Size by Type (2015-2020)
12.4 Central & South America Crohn’s Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview
13.1.3 Abbvie Crohn’s Disease Introduction
13.1.4 Abbvie Revenue in Crohn’s Disease Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Crohn’s Disease Introduction
13.2.4 Amgen Revenue in Crohn’s Disease Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Cambridge Antibody Technology
13.3.1 Cambridge Antibody Technology Company Details
13.3.2 Cambridge Antibody Technology Business Overview
13.3.3 Cambridge Antibody Technology Crohn’s Disease Introduction
13.3.4 Cambridge Antibody Technology Revenue in Crohn’s Disease Business (2015-2020)
13.3.5 Cambridge Antibody Technology Recent Development
13.4 Janssen Biotech
13.4.1 Janssen Biotech Company Details
13.4.2 Janssen Biotech Business Overview
13.4.3 Janssen Biotech Crohn’s Disease Introduction
13.4.4 Janssen Biotech Revenue in Crohn’s Disease Business (2015-2020)
13.4.5 Janssen Biotech Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Crohn’s Disease Introduction
13.5.4 Pfizer Revenue in Crohn’s Disease Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Tillotts Pharma
13.6.1 Tillotts Pharma Company Details
13.6.2 Tillotts Pharma Business Overview
13.6.3 Tillotts Pharma Crohn’s Disease Introduction
13.6.4 Tillotts Pharma Revenue in Crohn’s Disease Business (2015-2020)
13.6.5 Tillotts Pharma Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Crohn’s Disease Introduction
13.7.4 Johnson & Johnson Revenue in Crohn’s Disease Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Details
13.8.2 Boehringer Ingelheim Business Overview
13.8.3 Boehringer Ingelheim Crohn’s Disease Introduction
13.8.4 Boehringer Ingelheim Revenue in Crohn’s Disease Business (2015-2020)
13.8.5 Boehringer Ingelheim Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Crohn's Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Crohn's Disease Revenue
Table 3. Ranking of Global Top Crohn's Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Crohn's Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Drug Therapy
Table 7. Global Crohn's Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Crohn's Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Crohn's Disease Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Crohn's Disease Market Share by Regions (2015-2020)
Table 11. Global Crohn's Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Crohn's Disease Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Crohn's Disease Market Growth Strategy
Table 17. Main Points Interviewed from Key Crohn's Disease Players
Table 18. Global Crohn's Disease Revenue by Players (2015-2020) (Million US$)
Table 19. Global Crohn's Disease Market Share by Players (2015-2020)
Table 20. Global Top Crohn's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn's Disease as of 2019)
Table 21. Global Crohn's Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Crohn's Disease Product Solution and Service
Table 24. Date of Enter into Crohn's Disease Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Crohn's Disease Market Size by Type (2015-2020) (Million US$)
Table 27. Global Crohn's Disease Market Size Share by Type (2015-2020)
Table 28. Global Crohn's Disease Revenue Market Share by Type (2021-2026)
Table 29. Global Crohn's Disease Market Size Share by Application (2015-2020)
Table 30. Global Crohn's Disease Market Size by Application (2015-2020) (Million US$)
Table 31. Global Crohn's Disease Market Size Share by Application (2021-2026)
Table 32. North America Key Players Crohn's Disease Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Crohn's Disease Market Share (2019-2020)
Table 34. North America Crohn's Disease Market Size by Type (2015-2020) (Million US$)
Table 35. North America Crohn's Disease Market Share by Type (2015-2020)
Table 36. North America Crohn's Disease Market Size by Application (2015-2020) (Million US$)
Table 37. North America Crohn's Disease Market Share by Application (2015-2020)
Table 38. Europe Key Players Crohn's Disease Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Crohn's Disease Market Share (2019-2020)
Table 40. Europe Crohn's Disease Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Crohn's Disease Market Share by Type (2015-2020)
Table 42. Europe Crohn's Disease Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Crohn's Disease Market Share by Application (2015-2020)
Table 44. China Key Players Crohn's Disease Revenue (2019-2020) (Million US$)
Table 45. China Key Players Crohn's Disease Market Share (2019-2020)
Table 46. China Crohn's Disease Market Size by Type (2015-2020) (Million US$)
Table 47. China Crohn's Disease Market Share by Type (2015-2020)
Table 48. China Crohn's Disease Market Size by Application (2015-2020) (Million US$)
Table 49. China Crohn's Disease Market Share by Application (2015-2020)
Table 50. Japan Key Players Crohn's Disease Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Crohn's Disease Market Share (2019-2020)
Table 52. Japan Crohn's Disease Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Crohn's Disease Market Share by Type (2015-2020)
Table 54. Japan Crohn's Disease Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Crohn's Disease Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Crohn's Disease Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Crohn's Disease Market Share (2019-2020)
Table 58. Southeast Asia Crohn's Disease Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Crohn's Disease Market Share by Type (2015-2020)
Table 60. Southeast Asia Crohn's Disease Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Crohn's Disease Market Share by Application (2015-2020)
Table 62. India Key Players Crohn's Disease Revenue (2019-2020) (Million US$)
Table 63. India Key Players Crohn's Disease Market Share (2019-2020)
Table 64. India Crohn's Disease Market Size by Type (2015-2020) (Million US$)
Table 65. India Crohn's Disease Market Share by Type (2015-2020)
Table 66. India Crohn's Disease Market Size by Application (2015-2020) (Million US$)
Table 67. India Crohn's Disease Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Crohn's Disease Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Crohn's Disease Market Share (2019-2020)
Table 70. Central & South America Crohn's Disease Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Crohn's Disease Market Share by Type (2015-2020)
Table 72. Central & South America Crohn's Disease Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Crohn's Disease Market Share by Application (2015-2020)
Table 74. Abbvie Company Details
Table 75. Abbvie Business Overview
Table 76. Abbvie Product
Table 77. Abbvie Revenue in Crohn's Disease Business (2015-2020) (Million US$)
Table 78. Abbvie Recent Development
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Product
Table 82. Amgen Revenue in Crohn's Disease Business (2015-2020) (Million US$)
Table 83. Amgen Recent Development
Table 84. Cambridge Antibody Technology Company Details
Table 85. Cambridge Antibody Technology Business Overview
Table 86. Cambridge Antibody Technology Product
Table 87. Cambridge Antibody Technology Revenue in Crohn's Disease Business (2015-2020) (Million US$)
Table 88. Cambridge Antibody Technology Recent Development
Table 89. Janssen Biotech Company Details
Table 90. Janssen Biotech Business Overview
Table 91. Janssen Biotech Product
Table 92. Janssen Biotech Revenue in Crohn's Disease Business (2015-2020) (Million US$)
Table 93. Janssen Biotech Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Crohn's Disease Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. Tillotts Pharma Company Details
Table 100. Tillotts Pharma Business Overview
Table 101. Tillotts Pharma Product
Table 102. Tillotts Pharma Revenue in Crohn's Disease Business (2015-2020) (Million US$)
Table 103. Tillotts Pharma Recent Development
Table 104. Johnson & Johnson Company Details
Table 105. Johnson & Johnson Business Overview
Table 106. Johnson & Johnson Product
Table 107. Johnson & Johnson Revenue in Crohn's Disease Business (2015-2020) (Million US$)
Table 108. Johnson & Johnson Recent Development
Table 109. Boehringer Ingelheim Business Overview
Table 110. Boehringer Ingelheim Product
Table 111. Boehringer Ingelheim Company Details
Table 112. Boehringer Ingelheim Revenue in Crohn's Disease Business (2015-2020) (Million US$)
Table 113. Boehringer Ingelheim Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Crohn's Disease Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Drug Therapy Features
Figure 4. Global Crohn's Disease Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Others Case Studies
Figure 8. Crohn's Disease Report Years Considered
Figure 9. Global Crohn's Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Crohn's Disease Market Share by Regions: 2020 VS 2026
Figure 11. Global Crohn's Disease Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Crohn's Disease Market Share by Players in 2019
Figure 14. Global Top Crohn's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn's Disease as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Crohn's Disease Revenue in 2019
Figure 16. North America Crohn's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Crohn's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Crohn's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Crohn's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Crohn's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Crohn's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Crohn's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
クローン病診断・治療の世界市場（～2026年） Crohn's disease is a type of inflammatory bowel disease (IBD) that may affect any part of the gastrointestinal tract from mouth to anus. Signs and symptoms often include abdominal pain, diarrhea, fever, and weight loss. As the prevalence of the disease increases, it is expected to drive the Crohn's …- クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…
- 消退骨病の世界市場（～2026年） Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…
- 脳血管障害の世界市場（～2026年） Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is…
- 炎症性心疾患の世界市場（～2026年） Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment. Changing lifestyle resulting in higher prevalence of viral and f…